Trademark: 97037992
Status Date
Wednesday, February 28, 2024
Filing Date
Tuesday, September 21, 2021
Published for Opposition
Tuesday, February 7, 2023
36 Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription health care benefit coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurance, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify clinical benefits; prescription drug and healthcare benefit plan services, namely, providing information to patients regarding in-network services in the fields of disease management programs and chronic conditions
35 Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs management and retail pharmacy services; Drug utilization review services and drug and medical formulary cost management services; pharmaceutical and medical cost management services and drug utilization review services; in-network provider advisory services and consultancy services, strategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior and health care benefit plan healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans; cost management for pharmacy and heath care benefit services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits to identify potential cost savings
44 Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; health care services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance and providing healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare and pharmaceuticals; providing information in the field of healthcare to pharmacy benefit management services clients, consultants and brokers
Feb 29, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2024
Sou Extension 2 Granted
Feb 28, 2024
Sou Extension 2 Filed
Feb 28, 2024
Sou Teas Extension Received
Oct 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2023
Sou Extension 1 Granted
Sep 29, 2023
Sou Extension 1 Filed
Sep 29, 2023
Sou Teas Extension Received
Apr 4, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 3, 2023
Approved For Pub - Principal Register
Dec 15, 2022
Teas/Email Correspondence Entered
Dec 15, 2022
Correspondence Received In Law Office
Dec 15, 2022
Teas Response To Office Action Received
Jul 5, 2022
Notification Of Non-Final Action E-Mailed
Jul 5, 2022
Non-Final Action E-Mailed
Jul 5, 2022
Non-Final Action Written
Jun 23, 2022
Assigned To Examiner
Oct 24, 2021
New Application Office Supplied Data Entered
Sep 24, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
